BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22983827)

  • 21. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    Liu L; Yuan P; Wu C; Zhang X; Wang F; Guo H; Zhong R; Xu Y; Wu J; Yu D; Wu T; Zhang X; Nie S; Miao X; Lin D
    Lung Cancer; 2011 Jul; 73(1):110-5. PubMed ID: 21129812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
    Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
    Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.
    Liu HF; Liu JS; Deng JH; Wu RR
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28081275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan.
    Yin G; Morita M; Ohnaka K; Toyomura K; Hamajima N; Mizoue T; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Yasunami Y; Maekawa T; Takenaka K; Ichimiya H; Terasaka R
    J Epidemiol; 2012; 22(1):64-71. PubMed ID: 22186158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism].
    Hong CY; Xu Q; Yue Z; Zhang Y; Yuan Y
    Ai Zheng; 2009 Dec; 28(12):1291-7. PubMed ID: 19958624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.
    Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M
    Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
    Przybylowska-Sygut K; Stanczyk M; Kusinska R; Kordek R; Majsterek I
    Clin Breast Cancer; 2013 Feb; 13(1):61-8. PubMed ID: 23103366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
    Singh A; Singh N; Behera D; Sharma S
    Med Oncol; 2017 Apr; 34(4):64. PubMed ID: 28332164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.
    Li Y; Li S; Wu Z; Hu F; Zhu L; Zhao X; Cui B; Dong X; Tian S; Wang F; Zhao Y
    Med Oncol; 2013 Jun; 30(2):505. PubMed ID: 23430444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Cheng XD; Lu WG; Ye F; Wan XY; Xie X
    J Exp Clin Cancer Res; 2009 Jun; 28(1):91. PubMed ID: 19563645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt.
    Abdel-Rahman SZ; Soliman AS; Bondy ML; Omar S; El-Badawy SA; Khaled HM; Seifeldin IA; Levin B
    Cancer Lett; 2000 Oct; 159(1):79-86. PubMed ID: 10974409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population.
    Zhang Z; Wan J; Jin X; Jin T; Shen H; Lu D; Xia Z
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2614-9. PubMed ID: 16284386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer.
    Miao X; Zhang X; Zhang L; Guo Y; Hao B; Tan W; He F; Lin D
    Gastroenterology; 2006 Aug; 131(2):420-7. PubMed ID: 16890595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population.
    Wang Z; Xu B; Lin D; Tan W; Leaw S; Hong X; Hu X
    Lung Cancer; 2008 Oct; 62(1):99-104. PubMed ID: 18400332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population.
    Liu Y; Chen H; Chen L; Hu C
    Hepatogastroenterology; 2012 Jun; 59(116):977-80. PubMed ID: 22580644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
    Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
    Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity.
    Figg WD; Chau CH; Madan RA; Gulley JL; Gao R; Sissung TM; Spencer S; Beatson M; Aragon-Ching J; Steinberg SM; Dahut WL
    Clin Genitourin Cancer; 2013 Sep; 11(3):229-37. PubMed ID: 23684781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.
    Yue AM; Xie ZB; Guo SP; Wei QD; Yang XW
    Asian Pac J Cancer Prev; 2013; 14(1):355-8. PubMed ID: 23534753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
    Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.